Hankook Tire Worldwide (000240)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 23,100.00 |
|---|---|
| 52-week range | 22,000.00 – 36,450.00 |
| Return, 1 month / 3 months | −6.3% / −8.0% |
| Return, 1 year / 3 years | +1.2% / +137.9% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 50.7% |
| Worst drawdown (1 year) | -33.4% |
| Average daily value traded | 1,885.13M KRW |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hankook Tire Worldwide is the holding company of the Hankook tyre group, based in South Korea. Through its tyre business it develops and makes tyres for passenger cars, light trucks, buses and commercial vehicles, supplying vehicle makers with original equipment tyres and selling replacement tyres to drivers and distributors under the Hankook brand. Its customers include automotive manufacturers and aftermarket retailers and dealers in many countries around the world.
Hankook Tire Worldwide trades under the code 000240 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hankook Tire Worldwide (000240) trades on the Korea Stock Exchange in Korea. It last closed at KRW 23,100.00 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 191 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.2% and over the last three months it fell 8.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.7% | ||
| From 52-week high | -33.3% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.0% | ||
| 6-month return | -7.1% | ||
| 12-month return, skipping the last month | 8.0% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 50.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.4% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,885.13M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 82 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −12.2% |
|---|---|
| 1 month | −6.3% |
| 3 months | −8.0% |
| 6 months | −7.1% |
| 1 year | +1.2% |
| 3 years | +137.9% |
| 5 years | +70.7% |
Signals
| 50-day / 200-day average | 24,879.38 / 25,037.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 987.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | KRW 330.0000 |
| 30 Mar 2026 | KRW 800.0000 |
| 21 Aug 2025 | KRW 300.0000 |
| 28 Mar 2025 | KRW 790.0000 |
| 13 Aug 2024 | KRW 210.0000 |
| 27 Dec 2023 | KRW 700.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.